Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gauthier

Showing results (11-20 of 409) with videos related to

Pageof 41
Sort By:
Drugs & Aging|January 5, 2002
Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: epidemiology and managementS Gauthier
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
Practical guidelines for the antemortem diagnosis of senile dementia of the Alzheimer typeS Gauthier
Gerontology|January 7, 1999
Managing expectations in the long-term treatment of Alzheimer's diseaseS Gauthier
Journal of Psychiatry & Neuroscience : JPN|October 7, 2000
Should we encourage the use of high-dose vitamin E in persons with memory complaints as a preventive strategy against Alzheimer's disease?S Gauthier
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1986
Idiopathic spasmodic torticollis: pathophysiology and treatmentS Gauthier
Immunology|January 1, 1981
Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamideS Gauthier-Rahman
The Canadian Nurse|March 1, 1989
[Anger]C S Gauthier
The Canadian Nurse|November 1, 1988
[The denial of emotions. An essay on the causes of the denial of emotions in nurses facing the dying]C S Gauthier
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1992
Sustained release antiparkinson agents: controlled release levodopaS Gauthier, D Amyot
Annals of Neurology|November 1, 1983
Action tremor as a manifestation of chylomicron retention diseaseS Gauthier, A Sniderman
Pageof 41

Showing results (11-20 of 409) with videos related to

Sort By:
Pageof 41
Drugs & Aging|January 5, 2002
Cholinergic adverse effects of cholinesterase inhibitors in Alzheimer's disease: epidemiology and managementS Gauthier
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
Practical guidelines for the antemortem diagnosis of senile dementia of the Alzheimer typeS Gauthier
Gerontology|January 7, 1999
Managing expectations in the long-term treatment of Alzheimer's diseaseS Gauthier
Journal of Psychiatry & Neuroscience : JPN|October 7, 2000
Should we encourage the use of high-dose vitamin E in persons with memory complaints as a preventive strategy against Alzheimer's disease?S Gauthier
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|May 1, 1986
Idiopathic spasmodic torticollis: pathophysiology and treatmentS Gauthier
Immunology|January 1, 1981
Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamideS Gauthier-Rahman
The Canadian Nurse|March 1, 1989
[Anger]C S Gauthier
The Canadian Nurse|November 1, 1988
[The denial of emotions. An essay on the causes of the denial of emotions in nurses facing the dying]C S Gauthier
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 1, 1992
Sustained release antiparkinson agents: controlled release levodopaS Gauthier, D Amyot
Annals of Neurology|November 1, 1983
Action tremor as a manifestation of chylomicron retention diseaseS Gauthier, A Sniderman
Pageof 41